Persistent Acid Reflux Disease

  • STATUS
    Recruiting
Updated on 23 November 2020

Summary

Acid Reflux, Heartburn and currently taking proton pump inhibitors

 

Description

Blood tests and medical care are included.

Details
Condition Gastroesophageal Reflux Disease (GERD)
Clinical Study IdentifierTX232171
Last Modified on23 November 2020

Eligibility

Yes No Not Sure

Inclusion Criteria

Each patient must meet all of the following criteria to be eligible for
enrollment in this study
Patient is an ambulatory male or female (if female, nonpregnant) and is at least 18 years old at the Screening Visit
Patient has a diagnosis of GERD and reports experiencing GERD symptoms (heartburn or regurgitation) while taking standard proton pump inhibitor (PPI) therapy
Patient has evidence of pathological acid reflux
Female patients must not be pregnant and must agree to avoid pregnancy for the duration of the study
Patient must comply with study procedures
Exclusions
Patients who meet any of the following criteria will not be eligible to
participate in the study
Patient has a history of complete lack of GERD symptom response to PPI therapy
Patient has a significant medical or surgical history including conditions that would impact drug absorption or metabolism (such as bowel obstruction, diabetes, gastroparesis, hiatal hernia)
Patient reports pain or burning behind the breastbone or in the center of the upper stomach as his or her predominant symptom at the Screening Visit
Patient has received an investigational drug during the 30 days before the Screening Visit, or is planning to receive another investigational drug or use an investigational device at any time during the study
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note